Hearing · house
Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs
2025-04-01 · 14:15
Source status: Scheduled
Committee
Location
2123, Rayburn House Office Building
Video
Witnesses
Mr. Carl D’Ruiz, MPH
Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America
Mr. Scott Faber
Senior Vice President, Government Affairs
Mr. Kevin Menzel
Member, Board of Directors, Consumer Healthcare Products Association;
Ms. Kim Wezik, MPH
Director of Advocacy
Mr. Douglas Troutman
Interim Co-Chief Executive Officer
Official published hearing
Congress.gov explicitly associates this publication with this proceeding.
H.Hrg.119
EXAMINING THE FDA'S REGULATION OF OVER-THE-COUNTER MONOGRAPH DRUGS
2025-04-01 · GovInfo record 2025-09-04
Congress.gov lists this publication among several possible proceedings.
Documents
Witness documents
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Truth in Testimony · PDF
- Witness Truth in Testimony · PDF
- Witness Support Document · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Biography · PDF
- Witness Statement · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Statement · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Biography · PDF
- Witness Support Document · PDF
Hearing record
Committee activity
- Hearing Notice · Support Document · PDF
- The Honorable Brett Guthrie · Member Statements · PDF
- The Honorable Earl L. "Buddy" Carter · Member Statements · PDF
- The Honorable Frank Pallone · Member Statements · PDF
- The Honorable Diana DeGette · Member Statements · PDF
- Documents For the Record · Support Document · PDF
- Hearing Memorandum · Support Document · PDF
Source: https://api.congress.gov/v3/committee-meeting/119/house/118079